Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

EBR Systems (EBRCZ) EPS (Weighted Average and Diluted) (2023 - 2026)

EBR Systems recorded quarterly EPS (Weighted Average and Diluted) of -$0.38 in Q1 2026, down 1166.67% quarter-over-quarter from -$0.03 in Q4 2025, and down 35.71% year-over-year from -$0.59 in Q1 2025.

EBR Systems' EPS (Weighted Average and Diluted) history runs 4 years deep, the most recent figure standing at -$0.38 for Q1 2026.

  • In Q1 2026, EPS (Weighted Average and Diluted) fell 35.71% year-over-year to -$0.38; the TTM figure through Mar 2026 stood at -$0.47 (down 23.68% YoY), while the FY2025 annual figure was -$0.12, up 7.69% from the prior year.
  • EPS (Weighted Average and Diluted) came in at -$0.38 for Q1 2026 at EBR Systems, down from -$0.03 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in Q3 2023 to a low of -$0.38 in Q1 2026.
  • A 4-year average of -$0.09 and a median of -$0.03 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
  • On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 25.0% in 2025 and fell as far as 833.33% in 2025.
  • EBR Systems' EPS (Weighted Average and Diluted) stood at -$0.03 in 2023, then changed by 0.0% to -$0.03 in 2024, then changed by 0.0% to -$0.03 in 2025, then plunged by 1166.67% to -$0.38 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.38, -$0.03, and -$0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 EBR Systems - - 184,000.00 -0.38

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.38
Dec 31, 2025 -0.03
Sep 30, 2025 -0.03
Jun 30, 2025 -0.03
Mar 31, 2025 -0.28
Dec 31, 2024 -0.03
Sep 30, 2024 -0.03
Jun 30, 2024 -0.04
Mar 31, 2024 -0.03
Dec 31, 2023 -0.03
Sep 30, 2023 -0.03